State Ledger
Company profile

ALUMIS INC. CIK 1847367

Ticker
ALMS (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
South San Francisco, CA 94080
Fiscal year end
2025 (FY)
Market Data
Close
$6.56
Change
-$0.48
Change %
-6.82%
Volume
117,969

ALMS · trading date Oct 13, 2026 · previous close $7.04 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$24.05M
Net income
-$243.33M
Total assets
$411.94M
Total liabilities
$110.64M
Stockholders' equity
$301.30M
Cash & equivalents
$89.67M
Operating income
-$453.80M
Operating cash flow
-$369.52M
Capital expenditures
$653.0K

Fiscal year 2025, via 10-K filed 2026-03-19. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-1,886.9%
Net margin
-1,011.7%
Free cash flow
-$370.18M
Free cash flow margin
-1,539.2%
Liabilities / assets
26.9%
Equity / assets
73.1%
CapEx / revenue
2.7%
Operating cash flow / net income
1.52×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $24.05M -$243.33M $411.94M $110.64M $301.30M
2024 — -$294.23M $340.99M $80.89M $260.10M
2023 — -$154.99M $89.61M $53.50M -$339.26M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-09
Financials filed via
Form 10-K
filed 2026-03-19

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
South San Francisco, CA 94080
280 EAST GRAND AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies